Source of Funding


Summary

This firm appears to focus on private equity investments, but the mandate does not seem very explicit.
  • Investing Firm Name: Bryn Mawr Trust Company
  • Company Type: Family Office
  • Website: bryangarnier.com
  • Website (Other):
  • Private Equity?: FALSE
  • Private Debt?: FALSE
  • Infrastructure?: FALSE
  • Real Estate?: FALSE

Company Contacts



Contact 1
First name: Angela
Last name: Granese
Email: lspringinsfeld@bryangarnier.com
Confidence score: 94
Type of Email: personal
Number of Sources: 2


Contact 2
First name: Raymond
Last name: Kane
Email: bschapiro@bryangarnier.com
Confidence score: 94
Type of Email: personal
Number of Sources: 1


Contact 3
First name:
Last name:
Email: anayyar@bryangarnier.com
Confidence score: 94
Type of Email: personal
Number of Sources: 1

Location

 

  • Country:
  • City:

Due Diligence

Sources & Other Info

AUM (Wells Fargo Advisors, Llc): 266,000 M (1,047,791 accounts); investment-advisors.findthebest.com/l/34819/Wells-Fargo-Advisors-Llc

  • Confidence Scores: 94;94;94;94;94;94;94;94;94;94
  • This page last updated: 44561

Amount of Sources: 1;2;1;1;1;4;1;3;1;3

http://bryangarnier.com/home/about-us/senior-team;http://cannabisindustry.co.uk/2020/06/23/exploring-growth-in-the-european-medical-cannabis-market-health-europa;http://bryangarnier.com/portfolio/bryan-garnier-co-advises-locatel-in-its-merger-with-hoist-technology;http://bryangarnier.com/portfolio/bryan-garnier-co-advises-ogone-payment-services-and-its-main-shareholder-summit-partners-on-the-acquisition-of-ebs-e-billing-solutions;http://bryangarnier.com/portfolio/bryan-garnier-co-announces-it-has-advised-360-capital-partners-on-its-sale-of-16-stake-in-adomos;http://bryangarnier.com/portfolio/private-placement-oncoimmunity-as;http://yumpu.com/da/document/view/38420944/pandora-arsrapport-2010;http://vinci.com/vinci.nsf/de/item/finanzen-aktie-analysten-konsens.htm;http://bryangarnier.com/home/about-us/senior-team;http://bryangarnier.com/portfolio/bryan-garnier-co-acts-as-joint-bookrunner-and-joint-broker-to-aim-listed-4d-pharma-on-its-22-million-equity-fund-raising

http://healtheuropa.eu/exploring-growth-in-the-european-medical-cannabis-market/100849;http://bryangarnier.com/portfolio/cermaq-asa-sold-to-mitsubishi-corporation;http://vinci.com/vinci.nsf/en/item/finance-share-analysts-consensus.htm;http://bryangarnier.com/home/about-us/senior-team

http://bryangarnier.com/portfolio/private-placement-siem-offshore-asa;http://vinci.com/vinci.nsf/fr/item/finances-action-analystes-consensus.htm;http://bryangarnier.com/portfolio/bg-financial-advisor-blueberry-therapeutics-10-million-sterling-fundraising

http://bryangarnier.com/portfolio/equity-issue-and-debt-restructuring-norsun-asa

Disclaimer

This information is strictly subject to Raises.com/disclaimer and Raises.com/terms